Current Opinion in HIV and AIDS

Top Research Topics at Current Opinion in Hiv and Aids?

The foci of the journal are Immunology, Virology, Intensive care medicine, Immune system and Antiretroviral therapy. It connects the study in Immunology with the closely related area of Acquired immunodeficiency syndrome (AIDS). Current Opinion in Hiv and Aids covers research in Virology, particularly Virus, Transmission (medicine) and Simian immunodeficiency virus and how they are related with concepts in Extramural.

While the journal focused on Intensive care medicine, it was also able to explore topics like Psychological intervention, Clinical trial, Pharmacotherapy, Disease and Hiv treatment. T cell is a major topic of Immune system research.

• Immunology (35.10%)
• Virology (20.74%)
• Intensive care medicine (18.98%)

What are the most cited papers published in the journal?

• What are biomarkers (999 citations)
• Contribution of sexually transmitted infections to the sexual transmission of HIV. (243 citations)
• Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. (240 citations)

Research areas of the most cited articles at Current Opinion in Hiv and Aids:

The most cited papers mainly deal with areas of study such as Immunology, Virology, Immune system, Antiretroviral therapy and Intensive care medicine. The journal papers address concerns in Immunology which are intertwined with other disciplines, such as Transmission (medicine) and Acquired immunodeficiency syndrome (AIDS). While the most cited papers focused on Virology, they were also able to explore topics like HIV vaccine and Antibody.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Virus

The previous edition focused in particular on these issues:

The journal covers a variety of subjects, including Immunology, Pandemic, Disease, Intensive care medicine and Antiretroviral therapy. The work tackled in it goes beyond the discipline of Immunology as it also encompasses Acquired immunodeficiency syndrome (AIDS). Topics in Pandemic were tackled in line with various other fields like Epidemiology, Environmental health, Contact tracing, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Transmission (medicine).

Issues in Disease were discussed, taking into consideration concepts from other disciplines like B cell, Molecular epidemiology, Health care and Simian immunodeficiency virus. It explores issues in Intensive care medicine which can be linked to other research areas like Clinical trial, Fostemsavir, Cabotegravir, Integrase inhibitor and Doravirine. Antiretroviral therapy research presented in it encompasses a variety of subjects, including Viral persistence, Endocrinology, Computational biology and Bioinformatics.

The most cited articles from the last journal are:

• The interplay between HIV and COVID-19: summary of the data and responses to date. (18 citations)
• The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals. (4 citations)
• COVID-19 antibody development fueled by HIV-1 broadly neutralizing antibody research. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Current Opinion in Hiv and Aids (based on the number of publications) are:

• Jürgen K. Rockstroh (10 papers) absent at the last edition,
• Giuseppe Pantaleo (10 papers) absent at the last edition,
• Charles Flexner (9 papers) absent at the last edition,
• Marco Vitoria (9 papers) absent at the last edition,
• Nathan Ford (8 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Current Opinion in Hiv and Aids (based on the number of publications) are:

• Harvard University (47 papers) published 1 paper at the last edition the same number as at the previous edition,
• National Institutes of Health (37 papers) absent at the last edition,
• University of New South Wales (35 papers) absent at the last edition,
• University of California, San Francisco (31 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Johns Hopkins University (31 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.50% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 18.92% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 29.73% of all publications and 43.24% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.